Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
For GI health or situations where gradual absorption is required, delayed release is more appropriate
This batch of BPC-157 TB-500 (TB4) Blend has been third party lab tested and verified for quality
BPC-157 is a peptide that scientists have derived from human gastric juices
Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options
Bioavailability is central to the bpc 157 oral vs injection debate
